Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Raphael Viscidi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Disorders
Procedures
Concepts & Ideas
Phenomena
Sign-in to see full Profile
Network (preview)
31
Yolken, Robert
29
Shah, Keerti
16
Clayman, Barbara
13
Bobo, LD
12
Burk, Robert
10
Hildesheim, Allan
9
Herrero, Rolando
9
Coutlée, François
9
Quinn, Thomas
8
Crandall, Keith
7
Bartlett, John
7
Pérez-Losada, Marcos
7
Schiffman, Mark
7
Roden, Richard
7
Strickler, Howard
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Raphael Viscidi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Sutcliffe Siobhan; Kawachi Ichiro; Alderete John F; Gaydos Charlotte A; Jacobson Lisa P; Jenkins Frank J; Viscidi Raphael P; Zenilman Jonathan M; Platz Elizabeth A
Correlates of sexually transmitted infection histories in a cohort of American male health professionals.
Cancer causes & control : CCC 2009;20(9):1623-34.
-
2009: Xiao Jianchun; Buka Stephen L; Cannon Tyrone D; Suzuki Yasuhiro; Viscidi Raphael P; Torrey E Fuller; Yolken Robert H
Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring.
Microbes and infection / Institut Pasteur 2009;11(13):1011-8.
-
2009: Chen Yiping; Bord Evelyn; Tompkins Troy; Miller Janice; Tan Chen S; Kinkel R Philip; Stein Marion C; Viscidi Raphael P; Ngo Long H; Koralnik Igor J
Asymptomatic reactivation of JC virus in patients treated with natalizumab.
The New England journal of medicine 2009;361(11):1067-74.
-
2009: Grabowski Mary K; Viscidi Raphael P; Margolick Joseph B; Jacobson Lisa P; Shah Keerti V
Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.
Journal of medical virology 2009;81(7):1140-50.
-
2009: Wüthrich Christian; Dang Xin; Westmoreland Susan; McKay John; Maheshwari Atul; Anderson Matthew P; Ropper Allan H; Viscidi Raphael P; Koralnik Igor J
Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons.
Annals of neurology 2009;65(6):742-8.
-
2009: Einstein Mark H; Schiller John T; Viscidi Raphael P; Strickler Howard D; Coursaget Pierre; Tan Tina; Halsey Neal; Jenkins David
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
The Lancet infectious diseases 2009;9(6):347-56.
-
2009: Rollison Dana E; Helzlsouer Kathy J; Lee Ji-Hyun; Fulp William; Clipp Sandra; Hoffman-Bolton Judy A; Giuliano Anna R; Platz Elizabeth A; Viscidi Raphael P
Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1515-23.
-
2009: Khanna Nina; Wolbers Marcel; Mueller Nicolas J; Garzoni Christian; Du Pasquier Renaud A; Fux Christoph A; Vernazza Pietro; Bernasconi Enos; Viscidi Raphael; Battegay Manuel; Hirsch Hans H;
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
Journal of virology 2009;83(9):4404-11.
-
2009: Randhawa Parmjeet; Viscidi Raphael; Carter Joseph J; Galloway Denise A; Culp Tim D; Huang Cathy; Ramaswami Bala; Christensen Neil D
Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.
The Journal of general virology 2009;90(Pt 3):634-9.
-
2009: Trimble Cornelia L; Peng Shiwen; Kos Ferdynand; Gravitt Patti; Viscidi Raphael; Sugar Elizabeth; Pardoll Drew; Wu T C
A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):361-7.
-
2008: Severance Emily G; Bossis Ioannis; Dickerson Faith B; Stallings Cassie R; Origoni Andrea E; Sullens Anne; Yolken Robert H; Viscidi Raphael P
Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population.
Clinical and vaccine immunology : CVI 2008;15(12):1805-10.
-
2008: Randhawa P; Bohl D; Brennan D; Ruppert K; Ramaswami B; Storch G; March J; Shapiro R; Viscidi R
longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients.
Clinical and vaccine immunology : CVI 2008;15(10):1564-71.
-
2008: Huang Wen-Yi; Hayes Richard; Pfeiffer Ruth; Viscidi Raphael P; Lee Francis K; Wang Yun F; Reding Douglas; Whitby Denise; Papp John R; Rabkin Charles S
Sexually transmissible infections and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(9):2374-81.
-
2008: Dickerson Faith; Rubalcaba Elizabeth; Viscidi Raphael; Yang Shuojia; Stallings Cassie; Sullens Anne; Origoni Andrea; Leister Flora; Yolken Robert
Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia.
Schizophrenia research 2008;104(1-3):121-6.
-
2008: Görander Staffan; Lagergård Teresa; Romanik Malgorzata; Viscidi Raphael P; Martirosian Gayane; Liljeqvist Jan-Ake
Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.
Clinical and vaccine immunology : CVI 2008;15(4):675-80.
-
2008: Gillison Maura L; D'Souza Gypsyamber; Westra William; Sugar Elizabeth; Xiao Weihong; Begum Shahnaz; Viscidi Raphael
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Journal of the National Cancer Institute 2008;100(6):407-20.
-
2008: Carvajal-Rodríguez Antonio; Posada David; Pérez-Losada Marcos; Keller Emily; Abrams Elaine J; Viscidi Raphael P; Crandall Keith A
Disease progression and evolution of the HIV-1 env gene in 24 infected infants.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2008;8(2):110-20.
-
2008: Pintos Javier; Black Martin J; Sadeghi Nader; Ghadirian Parviz; Zeitouni Anthony G; Viscidi Raphael P; Herrero Rolando; Coutlée François; Franco Eduardo L
Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada.
Oral oncology 2008;44(3):242-50.
-
2008: Viscidi Raphael P; Shah Keerti V
Cancer. A skin cancer virus?
Science (New York, N.Y.) 2008;319(5866):1049-50.
-
2008: Wang I J; Viscidi R; Hwang K C; Lin T Y; Chen C J; Huang L M; Chen H H; Chen C J
Seroprevalence and risk factors for human papillomavirus in Taiwan.
Journal of tropical pediatrics 2008;54(1):14-8.
-
2007: Plitt Sabrina S; Sherman Susan G; Viscidi Raphael P; Strathdee Steffanie A; Fuller Crystal M; Taha Taha E
Human papillomavirus seroprevalence among young male and female drug users.
Sexually transmitted diseases 2007;34(9):676-80.
-
2007: Lundstig Annika; Stattin Pär; Persson Kenneth; Sasnauskas Kestutis; Viscidi Raphael P; Gislefoss Randi Elin; Dillner Joakim
No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.
International journal of cancer. Journal international du cancer 2007;121(5):1098-102.
-
2007: Sutcliffe Siobhan; Giovannucci Edward; Gaydos Charlotte A; Viscidi Raphael P; Jenkins Frank J; Zenilman Jonathan M; Jacobson Lisa P; De Marzo Angelo M; Willett Walter C; Platz Elizabeth A
Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(8):1573-80.
-
2007: Rodriguez Ana Cecilia; Burk Robert; Herrero Rolando; Hildesheim Allan; Bratti Concepcion; Sherman Mark E; Solomon Diane; Guillen Diego; Alfaro Mario; Viscidi Raphael; Morales Jorge; Hutchinson Martha; Wacholder Sholom; Schiffman Mark
The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.
Sexually transmitted diseases 2007;34(7):494-502.
-
2007: D'Souza Gypsyamber; Kreimer Aimee R; Viscidi Raphael; Pawlita Michael; Fakhry Carole; Koch Wayne M; Westra William H; Gillison Maura L
Case-control study of human papillomavirus and oropharyngeal cancer.
The New England journal of medicine 2007;356(19):1944-56.
-
2007: Pérez-Losada Marcos; Crandall Keith A; Zenilman Jonathan; Viscidi Raphael P
Temporal trends in gonococcal population genetics in a high prevalence urban community.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2007;7(2):271-8.
-
2007: Chen Chih-Jung; Viscidi Raphael P; Chuang Chih-Hsien; Huang Yhu-Chering; Chiu Cheng-Hsun; Lin Tzou-Yien
Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;38(2):126-30.
-
2007: Mbwana J; Viscidi R; Lyamuya E; Mhalu F; Chalamilla G; Liljeqvist J-A; Lagergård T
Prevalence of serum antibodies to human papilloma virus in patients with genital ulcer disease in an urban population of Tanzania.
Sexually transmitted infections 2007;83(1):64-5.
-
2007: Pérez-Losada Marcos; Crandall Keith A; Bash Margaret C; Dan Michael; Zenilman Jonathan; Viscidi Raphael P
Distinguishing importation from diversification of quinolone-resistant Neisseria gonorrhoeae by molecular evolutionary analysis.
BMC evolutionary biology 2007;7():84.
-
2006: Gambhira Ratish; Gravitt Patti E; Bossis Ioannis; Stern Peter L; Viscidi Raphael P; Roden Richard B S
Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Cancer research 2006;66(23):11120-4.
-
2006: Edwards C T T; Holmes E C; Pybus O G; Wilson D J; Viscidi R P; Abrams E J; Phillips R E; Drummond A J
Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection.
Genetics 2006;174(3):1441-53.
-
2006: Randhawa Parmjeet S; Gupta Gaurav; Vats Abhay; Shapiro Ron; Viscidi Raphael P
Immunoglobulin G, A, and M responses to BK virus in renal transplantation.
Clinical and vaccine immunology : CVI 2006;13(9):1057-63.
-
2006: Pinto Ligia A; Viscidi Raphael; Harro Clayton D; Kemp Troy J; García-Piñeres Alfonso J; Trivett Matthew; Demuth Franklin; Lowy Douglas R; Schiller John T; Berzofsky Jay A; Hildesheim Allan
Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Virology 2006;353(2):451-62.
-
2006: Pérez-Losada Marcos; Christensen Ryan G; McClellan David A; Adams Byron J; Viscidi Raphael P; Demma James C; Crandall Keith A
Comparing phylogenetic codivergence between polyomaviruses and their hosts.
Journal of virology 2006;80(12):5663-9.
-
2006: Jones-Engel Lisa; Engel Gregory A; Heidrich John; Chalise Mukesh; Poudel Narayan; Viscidi Raphael; Barry Peter A; Allan Jonathan S; Grant Richard; Kyes Randy
Temple monkeys and health implications of commensalism, Kathmandu, Nepal.
Emerging infectious diseases 2006;12(6):900-6.
-
2006: Silverberg Michael J; Schneider Michael F; Silver Barbara; Anastos Kathryn M; Burk Robert D; Minkoff Howard; Palefsky Joel; Levine Alexandra M; Viscidi Raphael P
Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Clinical and vaccine immunology : CVI 2006;13(4):511-9.
-
2006: Rollison Dana E; Engels Eric A; Halsey Neal A; Shah Keerti V; Viscidi Raphael P; Helzlsouer Kathy J
Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(3):543-50.
-
2006: Pérez-Losada Marcos; Browne Emily B; Madsen Aaron; Wirth Thierry; Viscidi Raphael P; Crandall Keith A
Population genetics of microbial pathogens estimated from multilocus sequence typing (MLST) data.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2006;6(2):97-112.
-
2006: Viscidi Raphael P; Clayman Barbara
Serological cross reactivity between polyomavirus capsids.
Advances in experimental medicine and biology 2006;577():73-84.
-
2006: Crandall Keith A; Pérez-Losada Marcos; Christensen Ryan G; McClellan David A; Viscidi Raphael P
Phylogenomics and molecular evolution of polyomaviruses.
Advances in experimental medicine and biology 2006;577():46-59.
-
2006: Edwards Charles T T; Holmes Edward C; Wilson Daniel J; Viscidi Raphael P; Abrams Elaine J; Phillips Rodney E; Drummond Alexei J
Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1.
BMC evolutionary biology 2006;6():28.
-
2005: Engels Eric A; Rollison Dana E; Hartge Patricia; Baris Dalsu; Cerhan James R; Severson Richard K; Cozen Wendy; Davis Scott; Biggar Robert J; Goedert James J; Viscidi Raphael P
Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma.
International journal of cancer. Journal international du cancer 2005;117(6):1013-9.
-
2005: Hariharan Sundaram; Cohen Eric P; Vasudev Brahm; Orentas Rimas; Viscidi Raphael P; Kakela Justin; DuChateau Brian
BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(11):2719-24.
-
2005: Pérez-Losada Marcos; Viscidi Raphael P; Demma James C; Zenilman Jonathan; Crandall Keith A
Population genetics of Neisseria gonorrhoeae in a high-prevalence community using a hypervariable outer membrane porB and 13 slowly evolving housekeeping genes.
Molecular biology and evolution 2005;22(9):1887-902.
-
2005: Zelmanowicz Alice de M; Schiffman Mark; Herrero Rolando; Goldstein Alisa M; Sherman Mark E; Burk Robert D; Gravitt Patti; Viscidi Ray; Schwartz Peter; Barnes Willard; Mortel Rodrigue; Silverberg Steven G; Buckland Julie; Hildesheim Allan
Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.
International journal of cancer. Journal international du cancer 2005;116(4):599-605.
-
2005: Yang Rongcun; Murillo Francisco Martinez; Delannoy Michael J; Blosser R Lee; Yutzy William H; Uematsu Satoshi; Takeda Kiyoshi; Akira Shizuo; Viscidi Raphael P; Roden Richard B S
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(12):7912-9.
-
2005: Rollison Dana E; Helzlsouer Kathy J; Halsey Neal A; Shah Keerti V; Viscidi Raphael P
Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1448-52.
-
2005: Yang Rongcun; Wheeler Cosette M; Chen Xiaojiang; Uematsu Satoshi; Takeda Kiyoshi; Akira Shizuo; Pastrana Diana V; Viscidi Raphael P; Roden Richard B S
Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Journal of virology 2005;79(11):6741-50.
-
2005: Kreimer Aimée R; Clifford Gary M; Snijders Peter J F; Castellsagué Xavier; Meijer Chris J L M; Pawlita Michael; Viscidi Raphael; Herrero Rolando; Franceschi Silvia;
HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas.
International journal of cancer. Journal international du cancer 2005;115(2):329-32.
-
2005: Engels Eric A; Chen Jinbo; Hartge Patricia; Cerhan James R; Davis Scott; Severson Richard K; Cozen Wendy; Viscidi Raphael P
Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):521-4.
-
2005: Viscidi Raphael P; Snyder Brad; Cu-Uvin Susan; Hogan Joseph W; Clayman Barbara; Klein Robert S; Sobel Jack; Shah Keerti V
Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):283-8.
-
2004: Engels Eric A; Switzer William M; Heneine Walid; Viscidi Raphael P
Serologic evidence for exposure to simian virus 40 in North American zoo workers.
The Journal of infectious diseases 2004;190(12):2065-9.
-
2004: Yang Rongcun; Murillo Francisco Martinez; Cui Hengmi; Blosser Richard; Uematsu Satoshi; Takeda Kiyoshi; Akira Shizuo; Viscidi Raphael P; Roden Richard B S
Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Journal of virology 2004;78(20):11152-60.
-
2004: Wang S S; Schiffman M; Herrero R; Carreon J; Hildesheim A; Rodriguez A C; Bratti M C; Sherman M E; Morales J; Guillen D; Alfaro M; Clayman B; Burk R D; Viscidi R P
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica.
British journal of cancer 2004;91(7):1269-74.
-
2004: Engels Eric A; Viscidi Raphael P; Galloway Denise A; Carter Joseph J; Cerhan James R; Davis Scott; Cozen Wendy; Severson Richard K; de Sanjose Silvia; Colt Joanne S; Hartge Patricia
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
Journal of the National Cancer Institute 2004;96(18):1368-74.
-
2004: Yang Rongcun; Murillo Francisco Martinez; Lin Ken-Yu; Yutzy William H; Uematsu Satoshi; Takeda Kiyoshi; Akira Shizuo; Viscidi Raphael P; Roden Richard B S
Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulations.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2624-31.
-
2004: Engels E A; Chen J; Viscidi R P; Shah K V; Daniel R W; Chatterjee N; Klebanoff M A
Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer.
American journal of epidemiology 2004;160(4):306-16.
-
2004: Castle Philip E; Schiffman Mark; Bratti M Concepcion; Hildesheim Allan; Herrero Rolando; Hutchinson Martha L; Rodriguez Ana Cecilia; Wacholder Sholom; Sherman Mark E; Kendall Hortense; Viscidi Raphael P; Jeronimo Jose; Schussler John E; Burk Robert D
A population-based study of vaginal human papillomavirus infection in hysterectomized women.
The Journal of infectious diseases 2004;190(3):458-67.
-
2004: Shah Keerti V; Galloway Denise A; Knowles Wendy A; Viscidi Raphael P
Simian virus 40 (SV40) and human cancer: a review of the serological data.
Reviews in medical virology 2004;14(4):231-9.
-
2004: Kim Tae Woo; Lee Jin Hyup; Hung Chien-Fu; Peng Shiwen; Roden Richard; Wang Mei-Cheng; Viscidi Raphael; Tsai Ya-Chea; He Liangmei; Chen Pei-Jer; Boyd David A K; Wu T-C
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Journal of virology 2004;78(9):4638-45.
-
2004: Kreimer Aimee R; Alberg Anthony J; Viscidi Rapheal; Gillison Maura L
Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
Sexually transmitted diseases 2004;31(4):247-56.
-
2004: Viscidi Raphael P; Schiffman Mark; Hildesheim Allan; Herrero Rolando; Castle Philip E; Bratti Maria C; Rodriguez Ana Cecilia; Sherman Mark E; Wang Sophia; Clayman Barbara; Burk Robert D
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(2):324-7.
-
2004: Kreimer Aimee R; Alberg Anthony J; Daniel Richard; Gravitt Patti E; Viscidi Rapheal; Garrett Elizabeth S; Shah Keerti V; Gillison Maura L
Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus.
The Journal of infectious diseases 2004;189(4):686-98.
-
2003: Viscidi Raphael P; Ahdieh-Grant Linda; Schneider Michael F; Clayman Barbara; Massad L Stewart; Anastos Kathryn M; Burk Robert D; Minkoff Howard; Palefsky Joel; Levine Alexandra; Strickler Howard
Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
The Journal of infectious diseases 2003;188(12):1834-44.
-
2003: Rodríguez A C; Castle P E; Smith J S; Bratti C; Hildesheim A; Schiffman M; Viscidi R; Burk R D; Ashley R L; Castellsagué X; Herrero R
A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica.
Sexually transmitted infections 2003;79(6):460-5.
-
2003: Herrero Rolando; Castellsagué Xavier; Pawlita Michael; Lissowska Jolanta; Kee Frank; Balaram Prabda; Rajkumar Thangarajan; Sridhar Hema; Rose Barbara; Pintos Javier; Fernández Leticia; Idris Ali; Sánchez María José; Nieto Adoración; Talamini Renato; Tavani Alessandra; Bosch F Xavier; Reidel Ulrich; Snijders Peter J F; Meijer Chris J L M; Viscidi Raphael; Muñoz Nubia; Franceschi Silvia;
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Journal of the National Cancer Institute 2003;95(23):1772-83.
-
2003: Wang S S; Schiffman M; Shields T S; Herrero R; Hildesheim A; Bratti M C; Sherman M E; Rodriguez A C; Castle P E; Morales J; Alfaro M; Wright T; Chen S; Clayman B; Burk R D; Viscidi R P
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.
British journal of cancer 2003;89(7):1248-54.
-
2003: de Sanjose Silvia; Shah Keerti V; Domingo-Domenech Eva; Engels Eric A; Fernandez de Sevilla Alberto; Alvaro Tomas; Garcia-Villanueva Mercedes; Romagosa Vicens; Gonzalez-Barca Eva; Viscidi Raphael P
Lack of serological evidence for an association between simian virus 40 and lymphoma.
International journal of cancer. Journal international du cancer 2003;104(4):522-4.
-
2003: Yang Rongcun; Yutzy William H; Viscidi Raphael P; Roden Richard B S
Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection.
The Journal of biological chemistry 2003;278(14):12546-53.
-
2003: Viscidi Raphael P; Rollison Dana E M; Viscidi Emma; Clayman Barbara; Rubalcaba Elizabeth; Daniel Richard; Major Eugene O; Shah Keerti V
Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.
Clinical and diagnostic laboratory immunology 2003;10(2):278-85.
-
2003: Viscidi Raphael P; Ahdieh-Grant Linda; Clayman Barbara; Fox Kelly; Massad Leslie S; Cu-Uvin Susan; Shah Keerti V; Anastos Kathryn M; Squires Kathleen E; Duerr Ann; Jamieson Denise J; Burk Robert D; Klein Robert S; Minkoff Howard; Palefsky Joel; Strickler Howard; Schuman Paula; Piessens Eva; Miotti Paolo
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
The Journal of infectious diseases 2003;187(2):194-205.
-
2003: Viscidi Raphael P; Demma James C
Genetic diversity of Neisseria gonorrhoeae housekeeping genes.
Journal of clinical microbiology 2003;41(1):197-204.
-
2002: Nakagawa Mayumi; Viscidi Raphael; Deshmukh Ian; Costa Maria Da; Palefsky Joel M; Farhat Sepideh; Moscicki Anna-Barbara
Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women.
Clinical and diagnostic laboratory immunology 2002;9(4):877-82.
-
2002: Zong Jianchao; Ciufo Dolores M; Viscidi Raphael; Alagiozoglou Lee; Tyring Stephen; Rady Peter; Orenstein Jan; Boto William; Kalumbuja Henry; Romano Nino; Melbye Mads; Kang Gyeong H; Boshoff Chris; Hayward Gary S
Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;23(3):119-48.
-
2000: Viscidi R P; Demma J C; Gu J; Zenilman J
Comparison of sequencing of the por gene and typing of the opa gene for discrimination of Neisseria gonorrhoeae strains from sexual contacts.
Journal of clinical microbiology 2000;38(12):4430-8.
-
2000: Alberg A J; Selhub J; Shah K V; Viscidi R P; Comstock G W; Helzlsouer K J
The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(7):761-4.
-
2000: Hinton E L; Bobo L D; Wu T C; Kurman R J; Viscidi R P
Detection of Chlamydia trachomatis DNA in archival paraffinized specimens from chronic salpingitis cases using the polymerase chain reaction.
Fertility and sterility 2000;74(1):152-7.
-
2000: Posada D; Crandall K A; Nguyen M; Demma J C; Viscidi R P
Population genetics of the porB gene of Neisseria gonorrhoeae: different dynamics in different homology groups.
Molecular biology and evolution 2000;17(3):423-36.
-
1999: Yu X F; Chen J; Shao Y; Beyrer C; Liu B; Wang Z; Liu W; Yang J; Liang S; Viscidi R P; Gu J; Gurri-Glass G; Lai S
Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China.
Journal of acquired immune deficiency syndromes (1999) 1999;22(2):180-8.
-
1999: Sun Y; Eluf-Neto J; Bosch F X; Muñoz N; Walboomers J M; Meijer C J; Shah K V; Clayman B; Viscidi R P
Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(10):935-40.
-
1999: Strickler H D; Viscidi R; Escoffery C; Rattray C; Kotloff K L; Goldberg J; Manns A; Rabkin C; Daniel R; Hanchard B; Brown C; Hutchinson M; Zanizer D; Palefsky J; Burk R D; Cranston B; Clayman B; Shah K V
Adeno-associated virus and development of cervical neoplasia.
Journal of medical virology 1999;59(1):60-5.
-
1998: Strickler H D; Schiffman M H; Shah K V; Rabkin C S; Schiller J T; Wacholder S; Clayman B; Viscidi R P
A survey of human papillomavirus 16 antibodies in patients with epithelial cancers.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1998;7(4):305-13.
-
1998: Contreras C E; Ploton I N; Siliciano R F; Karp C L; Viscidi R; Kumar N
Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.
Infection and immunity 1998;66(8):3579-90.
-
1998: Strunnikova N; Ray S C; Lancioni C; Nguyen M; Viscidi R P
Evolution of human immunodeficiency virus type 1 in relation to disease progression in children.
Journal of human virology 1998;1(3):224-39.
-
1998: Strickler H D; Burk R; Shah K; Viscidi R; Jackson A; Pizza G; Bertoni F; Schiller J T; Manns A; Metcalf R; Qu W; Goedert J J
A multifaceted study of human papillomavirus and prostate carcinoma.
Cancer 1998;82(6):1118-25.
-
1997: Strickler H D; Hildesheim A; Viscidi R P; Shah K V; Goebel B; Drummond J; Waters D; Sun Y; Hubbert N L; Wacholder S; Brinton L A; Han C L; Nasca P C; McClimens R; Turk K; Devairakkam V; Leitman S; Martin C; Schiller J T
Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assays.
Journal of clinical microbiology 1997;35(7):1751-6.
-
1997: Lambert J S; Viscidi R; Walker M C; Clayman B; Winget M; Wolff M; Schwartz D H
Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.
Clinical and diagnostic laboratory immunology 1997;4(3):302-8.
-
1997: Shah K V; Viscidi R P; Alberg A J; Helzlsouer K J; Comstock G W
Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(4):233-7.
-
1997: Viscidi R P; Kotloff K L; Clayman B; Russ K; Shapiro S; Shah K V
Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
Clinical and diagnostic laboratory immunology 1997;4(2):122-6.
-
1996: Quinn T C; Gaydos C; Shepherd M; Bobo L; Hook E W; Viscidi R; Rompalo A
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships.
JAMA : the journal of the American Medical Association 1996;276(21):1737-42.
-
1996: Iyengar S; Shah K V; Kotloff K L; Ghim S J; Viscidi R P
Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein.
Clinical and diagnostic laboratory immunology 1996;3(6):733-9.
-
1996: Sun Y; Hildesheim A; Brinton L A; Nasca P C; Trimble C L; Kurman R J; Viscidi R P; Shah K V
Human papillomavirus-specific serologic response in vulvar neoplasia.
Gynecologic oncology 1996;63(2):200-3.
-
1996: Schwartz D H; Viscidi R; Laeyendecker O; Song H; Ray S C; Michael N
Predominance of defective proviral sequences in an HIV + long-term non-progressor.
Immunology letters 1996;51(1-2):3-6.
-
1996: Koski G K; Ploton I N; Viscidi R; Kumar N
Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
Peptide research 1996;9(3):127-35.
-
1995: Wu T C; Guarnieri F G; Staveley-O'Carroll K F; Viscidi R P; Levitsky H I; Hedrick L; Cho K R; August J T; Pardoll D M
Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(25):11671-5.
-
1995: Strunnikova N; Ray S C; Livingston R A; Rubalcaba E; Viscidi R P
Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression.
Journal of virology 1995;69(12):7548-58.
-
1995: Ploton I N; Wizel B; Viscidi R; Kumar N
Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies.
Vaccine 1995;13(13):1161-9.
-
1995: Nonnenmacher B; Hubbert N L; Kirnbauer R; Shah K V; Muñoz N; Bosch F X; de Sanjosé S; Viscidi R; Lowy D R; Schiller J T
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.
The Journal of infectious diseases 1995;172(1):19-24.
-
1995: Müller M; Viscidi R P; Ulken V; Bavinck J N; Hill P M; Fisher S G; Reid R; Munoz N; Schneider A; Shah K V
Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population.
The Journal of investigative dermatology 1995;104(1):138-41.
-
1994: Sun Y; Shah K V; Müller M; Muñoz N; Bosch X F; Viscidi R P
Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
Journal of clinical microbiology 1994;32(9):2216-20.
-
1994: Sun Y; Eluf-Neto J; Bosch F X; Muñoz N; Booth M; Walboomers J M; Shah K V; Viscidi R P
Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(4):341-7.
-
1993: Viscidi R P; Sun Y; Tsuzaki B; Bosch F X; Muñoz N; Shah K V
Serologic response in human papillomavirus-associated invasive cervical cancer.
International journal of cancer. Journal international du cancer 1993;55(5):780-4.
-
1993: West S; Muñoz B; Bobo L; Quinn T C; Mkocha H; Lynch M; Mmbaga B B; Viscidi R
Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area.
Investigative ophthalmology & visual science 1993;34(11):3194-8.
-
1993: Yang B; Viscidi R; Yolken R
Quantitative measurement of nonisotopically labeled polymerase chain reaction product.
Analytical biochemistry 1993;213(2):422-5.
-
1993: Viscidi R P; Bobo L; Hook E W; Quinn T C
Transmission of Chlamydia trachomatis among sex partners assessed by polymerase chain reaction.
The Journal of infectious diseases 1993;168(2):488-92.
-
1993: Funkhouser A; Clements M L; Slome S; Clayman B; Viscidi R
Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.
AIDS research and human retroviruses 1993;9(7):627-32.
-
1993: Yang B; Yolken R; Viscidi R
Quantitative polymerase chain reaction by monitoring enzymatic activity of DNA polymerase.
Analytical biochemistry 1993;208(1):110-6.
-
1992: Gaydos C A; Bobo L; Welsh L; Hook E W; Viscidi R; Quinn T C
Gene typing of Chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion.
Sexually transmitted diseases 1992;19(6):303-8.
-
1992: Holland S M; Hudson A P; Bobo L; Whittum-Hudson J A; Viscidi R P; Quinn T C; Taylor H R
Demonstration of chlamydial RNA and DNA during a culture-negative state.
Infection and immunity 1992;60(5):2040-7.
-
1992: Coutlée F; Bobo L; Abbass H; Dalabetta G; Hook N E; Shah K; Viscidi R P
Detection of HPV-16 in cell lines and cervical lavage specimens by a polymerase chain reaction-enzyme immunoassay assay.
Journal of medical virology 1992;37(1):22-9.
-
1992: Müller M; Viscidi R P; Sun Y; Guerrero E; Hill P M; Shah F; Bosch F X; Muñoz N; Gissmann L; Shah K V
Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
Virology 1992;187(2):508-14.
-
1992: Lal R B; Rudolph D L; Kaplan J E; Hjelle B; Levine P H; Coligan J E; Viscidi R P
Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
Virology 1992;186(1):274-9.
-
1992: Newburg D S; Viscidi R P; Ruff A; Yolken R H
A human milk factor inhibits binding of human immunodeficiency virus to the CD4 receptor.
Pediatric research 1992;31(1):22-8.
-
1991: Bobo L; Coutlee F; Yolken R H; Quinn T; Viscidi R P
Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay.
Journal of clinical microbiology 1991;29(12):2912.
-
1991: Coutlée F; Saint-Antoine P; Olivier C; Voyer H; Kessous-Elbaz A; Berrada F; Bégin P; Giroux L; Viscidi R
Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA.
Journal of clinical microbiology 1991;29(11):2461-7.
-
1991: Coutlée F; Saint-Antoine P; Olivier C; Vessous-Elbaz A; Voyer H; Berrada F; Bégin P; Giroux L; Viscidi R
Discordance between primer pairs in the polymerase chain reaction for detection of human immunodeficiency virus type 1: a role for taq polymerase inhibitors.
The Journal of infectious diseases 1991;164(4):817-8.
-
1991: Coutleè F; Bobo L; Mayur K; Yolken R H; Viscidi R P
Immunodetection of DNA with biotinylated RNA probes: a study of reactivity of a monoclonal antibody to DNA-RNA hybrids.
Analytical biochemistry 1991;198(1):217.
-
1991: Bobo L; Munoz B; Viscidi R; Quinn T; Mkocha H; West S
Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay.
Lancet 1991;338(8771):847-50.
-
1991: Coutlée F; Yang B; Bobo L; Mayur K; Yolken R; Viscidi R
Enzyme immunoassay for detection of hybrids between PCR-amplified HIV-1 DNA and a RNA probe: PCR-EIA.
AIDS research and human retroviruses 1991;7(9):787.
-
1991: Coutlée F; Viscidi R P; Saint-Antoine P; Kessous A; Yolken R H
The polymerase chain reaction: a new tool for the understanding and diagnosis of HIV-1 infection at the molecular level.
Molecular and cellular probes 1991;5(4):241-59.
-
1991: Bleul C; Müller M; Frank R; Gausepohl H; Koldovsky U; Mgaya H N; Luande J; Pawlita M; ter Meulen J; Viscidi R
Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.
Journal of clinical microbiology 1991;29(8):1579-88.
-
1991: Yolken R H; Li S; Perman J; Viscidi R
Persistent diarrhea and fecal shedding of retroviral nucleic acids in children infected with human immunodeficiency virus.
The Journal of infectious diseases 1991;164(1):61-6.
-
1991: Coutlée F; Shah K V; Rader J S; Currie J L; Viscidi R P
Detection of transcripts of human papillomaviruses 16 and 18 in cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization.
Journal of clinical microbiology 1991;29(5):968-74.
-
1991: Yolken R H; Sierra-Honigmann A M; Viscidi R P
Solid phase capture method for the specific amplification of microbial nucleic acids--avoidance of false-positive and false-negative reactions.
Molecular and cellular probes 1991;5(2):151-6.
-
1991: Kinney J S; Conway J H; Hilgartner M W; Clayman B; Mayur K; Yolken R H; Viscidi R P
Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients.
American journal of hematology 1991;36(1):35-41.
-
1991: Viscidi R P; Hill P M; Li S J; Cerny E H; Vlahov D; Farzadegan H; Halsey N; Kelen G D; Quinn T C
Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
Journal of acquired immune deficiency syndromes 1991;4(12):1190-8.
-
1990: Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements M L; Clayman B; Fernie B; Smith G
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.
AIDS research and human retroviruses 1990;6(11):1251-6.
-
1990: Bobo L; Coutlee F; Yolken R H; Quinn T; Viscidi R P
Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay.
Journal of clinical microbiology 1990;28(9):1968-73.
-
1990: Coutlee F; Rubalcaba E A; Viscidi R P; Gern J E; Murphy P A; Lederman H M
Quantitative detection of messenger RNA by solution hybridization and enzyme immunoassay.
The Journal of biological chemistry 1990;265(20):11601-4.
-
1990: Coutlée F; Yang B Z; Bobo L; Mayur K; Yolken R; Viscidi R
Enzyme immunoassay for detection of hybrids between PCR-amplified HIV-1 DNA and a RNA probe: PCR-EIA.
AIDS research and human retroviruses 1990;6(6):775-84.
-
1990: Viscidi R P
Modification of cytosine residues on DNA.
Methods in enzymology 1990;184():600-7.
-
1989: Newman C L; Modlin J; Yolken R H; Viscidi R P
Solution hybridization and enzyme immunoassay for biotinylated DNA-RNA hybrids to detect enteroviral RNA in cell culture.
Molecular and cellular probes 1989;3(4):375-82.
-
1989: Viscidi R P; Mayur K; Lederman H M; Frankel A D
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.
Science (New York, N.Y.) 1989;246(4937):1606-8.
-
1989: Coutlée F; Bobo L; Mayur K; Yolken R H; Viscidi R P
Immunodetection of DNA with biotinylated RNA probes: a study of reactivity of a monoclonal antibody to DNA-RNA hybrids.
Analytical biochemistry 1989;181(1):96-105.
-
1989: Coutlee F; Yolken R H; Viscidi R P
Nonisotopic detection of RNA in an enzyme immunoassay using a monoclonal antibody against DNA-RNA hybrids.
Analytical biochemistry 1989;181(1):153-62.
-
1989: Coutlee F; Viscidi R P; Yolken R H
Comparison of colorimetric, fluorescent, and enzymatic amplification substrate systems in an enzyme immunoassay for detection of DNA-RNA hybrids.
Journal of clinical microbiology 1989;27(5):1002-7.
-
1989: Yolken R H; Coutlee F; Viscidi R P
New prospects for the diagnosis of viral infections.
The Yale journal of biology and medicine 1989;62(2):131-9.
-
1989: Viscidi R P; O'Meara C; Farzadegan H; Yolken R
Monoclonal antibody solution hybridization assay for detection of human immunodeficiency virus nucleic acids.
Journal of clinical microbiology 1989;27(1):120-5.
-
1989: Kinney J S; Viscidi R P; Vonderfecht S L; Eiden J J; Yolken R H
Monoclonal antibody assay for detection of double-stranded RNA and application for detection of group A and non-group A rotaviruses.
Journal of clinical microbiology 1989;27(1):6-12.
-
1988: Viscidi R; Farzadegan H; Leister F; Francisco M L; Yolken R
Enzyme immunoassay for detection of human immunodeficiency virus antigens in cell cultures.
Journal of clinical microbiology 1988;26(3):453-8.
-
1987: Viscidi R P; Yolken R G
Molecular diagnosis of infectious diseases by nucleic acid hybridization.
Molecular and cellular probes 1987;1(1):3-14.
-
1986: Miotti P G; Viscidi R P; Eiden J; Cerny E; Yolken R H
Centrifugation-augmented solid-phase immunoassay (CASPIA) for the rapid diagnosis of infectious diseases.
The Journal of infectious diseases 1986;154(2):301-8.
-
1986: Viscidi R P; Connelly C J; Yolken R H
Novel chemical method for the preparation of nucleic acids for nonisotopic hybridization.
Journal of clinical microbiology 1986;23(2):311-7.
-
1986: Yolken R H; Miotti P; Viscidi R
Immunoassays for the diagnosis and study of viral gastroenteritis.
Pediatric infectious disease 1986;5(1 Suppl):S46-52.
-
1985: Hanvanich M; Viscidi R; Laughon B E; Bartlett J G; Yolken R H
Stool desorbing activity: a possible cause of false-positive reactions in competitive enzyme immunoassays.
Journal of clinical microbiology 1985;21(2):184-8.
-
1984: Laughon B E; Viscidi R P; Gdovin S L; Yolken R H; Bartlett J G
Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens.
The Journal of infectious diseases 1984;149(5):781-8.
-
1984: Viscidi R; Laughon B E; Hanvanich M; Bartlett J G; Yolken R H
Improved enzyme immunoassays for the detection of antigens in fecal specimens. Investigation and correction of interfering factors.
Journal of immunological methods 1984;67(1):129-43.
-
1983: Viscidi R P; Yolken R H; Laughon B E; Bartlett J G
Enzyme immunoassay for detection of antibody to toxins A and B of Clostridium difficile.
Journal of clinical microbiology 1983;18(2):242-7.
-
1983: Viscidi R; Laughon B E; Yolken R; Bo-Linn P; Moench T; Ryder R W; Bartlett J G
Serum antibody response to toxins A and B of Clostridium difficile.
The Journal of infectious diseases 1983;148(1):93-100.
-
1982: Viscidi R; Geller A; Caplan W; Natsios G A; Gleckman R A
Prosthetic valve endocarditis caused by Mycobacterium chelonei: case report and literature review.
Heart & lung : the journal of critical care 1982;11(6):555-9.
-
1981: Viscidi R; Willey S; Bartlett J G
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
Gastroenterology 1981;81(1):5-9.
-
1981: Viscidi R P; Bartlett J G
Antibiotic-associated pseudomembranous colitis in children.
Pediatrics 1981;67(3):381-6.
Sign-in to see more
